Cargando…
Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2
Ejemplares similares
-
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant
por: Thorne, Lucy G, et al.
Publicado: (2021) -
Evolution of enhanced innate immune evasion by SARS-CoV-2
por: Thorne, Lucy G., et al.
Publicado: (2021) -
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant
por: Reuschl, Ann-Kathrin, et al.
Publicado: (2021) -
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
por: White, Kris M., et al.
Publicado: (2021) -
Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches
por: Cakir, Merve, et al.
Publicado: (2021)